Mining Biomedical Literature to Extract Pharmacokinetic Drug-Drug Interactions

Polypharmacy is a general clinical practice, there is a high chance that multiple administered drugs will interfere with each other, such phenomenon is called drug-drug interaction (DDI). DDI occurs when drugs administered change each other’s pharmacokinetic (PK) or pharmacodynamic (PD) response. DDIs in many ways affect the overall effectiveness of the drug or at some times pose a risk of serious side effects to the patients thus, it becomes very challenging to for the successful drug development and clinical patient care. Biomedical literature is rich source for in-vitro and in-vivo DDI reports and there is growing need to automated methods to extract the DDI related information from unstructured text. In this work we present an ontology (PK ontology), which defines annotation guidelines for annotation of PK DDI studies. Using the ontology we have put together a corpora of PK DDI studies, which serves as excellent resource for training machine learning, based DDI extraction algorithms. Finally we demonstrate the use of PK ontology and corpora for extracting PK DDIs from biomedical literature using machine learning algorithms.

[1]  Thomas Gärtner,et al.  On Graph Kernels: Hardness Results and Efficient Alternatives , 2003, COLT.

[2]  A. Sabers,et al.  Newer anticonvulsants: comparative review of drug interactions and adverse effects. , 2000, Drugs.

[3]  Lang Li,et al.  Extraction of drug-drug interactions using all paths graph kernel , 2011 .

[4]  Xu Han,et al.  An integrated pharmacokinetics ontology and corpus for text mining , 2013, BMC Bioinformatics.

[5]  R. Hamilton,et al.  Frequency of Hospitalization after Exposure to Known Drug‐Drug Interactions in a Medicaid Population , 1998, Pharmacotherapy.

[6]  A. Laupacis,et al.  Drug-drug interactions among elderly patients hospitalized for drug toxicity. , 2003, JAMA.

[7]  Jari Björne,et al.  BioInfer: a corpus for information extraction in the biomedical domain , 2007, BMC Bioinformatics.

[8]  Jun'ichi Tsujii,et al.  GENIA corpus - a semantically annotated corpus for bio-textmining , 2003, ISMB.

[9]  Xu Han,et al.  Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions , 2012, PLoS Comput. Biol..

[10]  Goran Nenadic,et al.  The GNAT library for local and remote gene mention normalization , 2011, Bioinform..

[11]  A. Rostami-Hodjegan,et al.  'In silico' simulations to assess the 'in vivo' consequences of 'in vitro' metabolic drug-drug interactions. , 2004, Drug discovery today. Technologies.

[12]  Christopher D. Manning,et al.  Generating Typed Dependency Parses from Phrase Structure Parses , 2006, LREC.

[13]  Constantin F. Aliferis,et al.  Extracting Drug-Drug Interaction Articles from MEDLINE to Improve the Content of Drug Databases , 2005, AMIA.

[14]  C. A. Jankel,et al.  Epidemiology of Drug-Drug Interactions as a Cause of Hospital Admissions , 1993, Drug safety.

[15]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[16]  I. H. Segel Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .

[17]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[18]  Goran Nenadic,et al.  LINNAEUS: A species name identification system for biomedical literature , 2010, BMC Bioinformatics.

[19]  B. Stricker,et al.  Hospitalisations and emergency department visits due to drug–drug interactions: a literature review , 2007, Pharmacoepidemiology and drug safety.

[20]  Shreyas Karnik,et al.  CAMP: a useful resource for research on antimicrobial peptides , 2009, Nucleic Acids Res..

[21]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[22]  Chitta Baral,et al.  Discovering drug–drug interactions: a text-mining and reasoning approach based on properties of drug metabolism , 2010, Bioinform..

[23]  Alfonso Valencia,et al.  Overview of BioCreAtIvE: critical assessment of information extraction for biology , 2005, BMC Bioinformatics.

[24]  César de Pablo-Sánchez,et al.  Using a shallow linguistic kernel for drug-drug interaction extraction , 2011, J. Biomed. Informatics.

[25]  Paloma Martínez,et al.  A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents , 2011, BMC Bioinformatics.

[26]  Jenny Y Chien,et al.  STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE , 2006, Drug Metabolism and Disposition.

[27]  F. Guengerich Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[28]  Thomas C. Rindflesch,et al.  MedTag: A Collection of Biomedical Annotations , 2005, LBLODMBS@IDMB.

[29]  Zeruesenay Desta,et al.  Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients , 2010, Journal of clinical pharmacology.

[30]  Lang Li,et al.  Literature mining on pharmacokinetics numerical data: A feasibility study , 2009, J. Biomed. Informatics.

[31]  Christopher G Chute,et al.  National Center for Biomedical Ontology: advancing biomedicine through structured organization of scientific knowledge. , 2006, Omics : a journal of integrative biology.

[32]  Cynthia L. Smith,et al.  The Mammalian Phenotype Ontology as a tool for annotating, analyzing and comparing phenotypic information , 2004, Genome Biology.

[33]  B. Ring,et al.  Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[34]  Natalya F. Noy,et al.  Protégé: A Tool for Managing and Using Terminology in Radiology Applications , 2007, Journal of Digital Imaging.

[35]  Mark A. Musen,et al.  Enabling enrichment analysis with the Human Disease Ontology , 2011, J. Biomed. Informatics.

[36]  Shreyas Karnik,et al.  Analysis of Intrinsically Disordered Regions in proteins Using Recurrence Quantification Analysis , 2011, Int. J. Bifurc. Chaos.

[37]  D. Harron Clinical pharmacokinetics: Concepts and applications (2nd edn.) , 1989 .

[38]  Amedeo Napoli,et al.  Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing , 2006, OTM Workshops.